SUNLENCA cpr pell 300 mg 5 pce
7680683860011
CH-68386
J05AX31
08.03.0.
Reimbursement limitations:
SUNLENCA
Sunlenca est indiqué, en association avec un traitement antirétroviral de fond optimisé, pour le traitement …
1 / 3
google
Details
- Product number
- 6838601
- CPT
- -
- Packaging group
- 5
- Unit
- Tablette(n)
- Composition
- lenacapavirum 300 mg ut lenacapavirum natricum, copovidonum, poloxamerum 407, mannitolum, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 172 (flavum), E 172 (nigrum), E 172 (rubrum), pro compresso obducto corresp. natrium max. 17.93 mg.
Articles (1)
Sunlenca, Filmtabletten
Filmtabletten
5
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
300.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 3404.75
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/11/2024
Authorization holder
Gilead Sciences Switzerland Sàrl
6300 Zug
Authorization information
- Swissmedic authorization number
- 68386
- Drug name
- Sunlenca, Filmtabletten
- Galenic form
- FILM
- ATC Code
- J05AX31
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 07/07/2023
- Authorization expiration date
- 06/07/2028
- IT number
- 08.03.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SUNLENCA cpr pell 300 mg 5 pce
- Description (DE)
- SUNLENCA Filmtabl 300 mg 5 Stk
- Market launch
- 07/07/2023
- Narcotic (BTM)
- No